Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

TxA2/PGH2 antagonists described by Terumo

Aug. 30, 1996

Fibrinogen antagonists claimed by Thomae

Aug. 30, 1996

Fibrinogen antagonists from Nippon Steel

Aug. 30, 1996

Glaxo Wellcome claims fibrinogen antagonists

Aug. 30, 1996

Fujisawa obtains marketing rights for ReoPro

Aug. 30, 1996

Terumo claims antithrombotic/antiallergy agents

Aug. 23, 1996

Fibrinogen antagonists in SmithKline Beecham's pipeline

Aug. 23, 1996

Corvas describes Factor Xa inhibitors

Aug. 23, 1996

More thrombin inhibitors from BioChem Pharma

Aug. 23, 1996

BioChem Pharma claims thrombin inhibitors for coagulopathies

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...